[Invasive candidiasis in newborns: diagnosis, treatment and prophylaxis]

Insights

Invasive fungal infections, particularly invasive candidiasis (IC), pose significant risks in neonatal intensive care units (NICUs). This review outlines key strategies for monitoring, preventing, and treating IC in newborns to reduce infant morbidity and mortality.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Critical Care Pediatrics

Background:

  • Invasive fungal infections (IFIs) are a growing concern in neonatal intensive care units (NICUs).
  • Invasive candidiasis (IC) significantly contributes to morbidity and mortality, particularly in premature infants.
  • Effective management strategies for neonatal IC are crucial.

Purpose of the Study:

  • To review and propose actionable recommendations for the management of invasive candidiasis (IC) in newborn infants.
  • To provide guidance on monitoring, prevention, treatment, and follow-up of IC in the NICU setting.
  • To address the increasing incidence of IFIs in vulnerable neonatal populations.

Main Methods:

  • Systematic literature review of current guidelines and research on neonatal invasive candidiasis.
  • Analysis of epidemiological data on IC incidence and outcomes in NICU populations.
  • Synthesis of evidence-based practices for antifungal therapy and infection control.

Main Results:

  • Identification of high-risk factors for IC development in preterm neonates.
  • Evaluation of diagnostic challenges and optimal monitoring approaches for early detection.
  • Assessment of current treatment protocols and emerging therapeutic options for Candida infections.
  • Review of preventative measures, including antifungal prophylaxis and hygiene practices.

Conclusions:

  • Standardized protocols for monitoring, prevention, and treatment are essential for reducing IC burden in NICUs.
  • Early diagnosis and prompt, appropriate antifungal therapy are critical for improving outcomes in neonates with IC.
  • Multidisciplinary collaboration is key to implementing effective IC management strategies in neonatal care.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
782